IP Library Granted Patent US 11,306,293
Granted Patent B2
US 11,306,293 · App. 16/737,390 · Granted Apr 19, 2022

Method for virus propagation

Inventors: Ann-Christin Magnusson (Uppsala, SE); Mats Lundgren (Uppsala, SE); Eva Blanck (Uppsala, SE); Christine Sund Lundstrom (Uppsala, SE)
Assignee: Cytiva Sweden AB
C12N7/00C12N5/0686C12N9/88C12N15/86A61K39/00C12N2720/12331C12N2720/12343C12N2720/12351
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,306,293
App. No.
16/737,390
Granted
Apr 19, 2022
Kind
B2
Abstract

The present invention relates to a method for virus propagation. More closely the invention relates to a method for animal component free propagation and production of rotavirus (RV) using recombinant trypsin.

Claims (10)

1. A method for rotavirus (RV) production comprising the following steps: cultivating cells in a bioreactor, infecting the cells with RV by activation with recombinant trypsin, and propagating the RV within said bioreactor in the presence of recombinant trypsin for maintenance/propagation, wherein the trypsin concentration is about 10 μg/ml for RV activation and about 5 μg/ml for maintenance/propagation.

2. The method according to claim 1 , wherein the cell cultivation is performed in VACCINEXPRESS medium.

3. The method according to claim 1 , wherein the bioreactor is a T-flask or spinner flask.

4. The method according to claim 1 , wherein the bioreactor is a disposable bag on a rocking platform, preferably a Wave bioreactor, or a stirred tank.

5. The method according to claim 1 , wherein the cell cultivation is performed on microcarriers.

6. The method according to claim 1 , wherein the microcarriers are sterilized microcarriers, preferably Cytodex gamma.

7. A method for rotavirus (RV) production comprising the following steps: cultivating cells in a bioreactor, infecting the cells with RV by activation with recombinant trypsin, and propagating the RV within said bioreactor in the presence of recombinant trypsin for maintenance/propagation, wherein the cell cultivation is performed on microcarriers, and wherein the trypsin concentration is about 20 μg/ml for RV activation and about 7 μg/ml for maintenance/propagation.

8. The method according to claim 1 , wherein the cells are Vero cells.

9. Use of the RV produced according to claim 1 for formulation of a vaccine against rotavirus caused disease.

10. Use of the RV produced according to claim 1 as a viral vector for gene therapy.

Assignments (2)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 054262/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2020
From: MAGNUSSON, ANN-CHRISTIN; LUNDGREN, MATS; BLANCK, EVA; LUNDSTROM, CHRISTINE SUND
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 051453/0018 →